JPRN-UMIN000008710Recruiting未知
Randomized phase II study comparing pegylated interferon alpha-2b combined with intra-arterial 5-fluorouracil and sorafenib alone for advanced hepatocellular carcinoma - Comparing pegylated interferon alpha-2b combined with 5-fluorouracil and sorafenib for advanced hepatocellular carcinoma
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Iwate Medical University
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 80years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Exclusion criteria for treatment were as follows:1) pregnancy women 2) patients who had allergic disorder and severe disease
Investigators
Similar Trials
Completed
Phase 2
Gemcitabine with the standard dose (1000 mg/m2) is equal to low dose (250 mg/m2) with just prolongation of the infusion time in Patients with Advanced Pancreatic cancerCancerPACTR201901862142418South Egypt cancer Institute100
Completed
Phase 2
Oral drug therapy as palliative chemotherapy in Head and Neck cancersCTRI/2014/07/004791Tata Memorial Hospital110
Not yet recruiting
Phase 2
A clinical trial comparing pulmonary complications in two routes of gastric conduit placement after esophagectomyCTRI/2024/02/062245AIIMS NEW DELHI
Completed
Phase 2
A phase II randomized controlled trial comparing perioperative mFOLFOXIRI with perioperative chemoradiotherapy for locally advanced rectal cancer.Rectal cancerJPRN-UMIN000018624Osaka Medical College Hospital34
Recruiting
Phase 2
A randomized controlled phase 2 trial comparing the safety and usefulness of robot-assisted esophagectomy and thoracoscopicJPRN-jRCT1040220153Takeuchi Hiroya90